Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gali Bar

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Emotion (Washington, D.C.)|April 20, 2011
Measuring children's regulation of emotion-expressive behaviorYair Bar-Haim, Gali Bar-Av, Avi Sadeh
Biological Psychiatry|January 21, 2004
High-dose glycine added to olanzapine and risperidone for the treatment of schizophreniaUriel Heresco-Levy, Marina Ermilov, Pesah Lichtenberg, et al.
The Israel Journal of Psychiatry and Related Sciences|September 2, 2005
Characteristics of schizophrenia residents and staff rejection in community mental health hostelsEynat Levy, Gaby Shefler, Uri Loewenthal, et al.
The International Journal of Neuropsychopharmacology|December 1, 2007
Reduced prepulse inhibition is associated with increased hypnotizabilityPesach Lichtenberg, Ehud Even-Or, Gali Bar, et al.
Schizophrenia Research|February 6, 2007
High glycine levels are associated with prepulse inhibition deficits in chronic schizophrenia patientsUriel Heresco-Levy, Gali Bar, Raz Levin, et al.
Biological Psychiatry|September 15, 2004
Placebo-controlled trial of lamotrigine added to conventional and atypical antipsychotics in schizophreniaIlana Kremer, Agnes Vass, Ielena Gorelik, et al.
The Israel Medical Association Journal : IMAJ|May 1, 2017
Deliberate Self-Harm in Older Adults: A General Hospital Emergency Department SurveyIrina Briskman, Assaf Shelef, Uri Berger, et al.
Biological Psychiatry|March 23, 2005
D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophreniaUriel Heresco-Levy, Daniel C Javitt, Richard Ebstein, et al.
The American Journal of Psychiatry|December 20, 2015
Ultra-Low-Dose Buprenorphine as a Time-Limited Treatment for Severe Suicidal Ideation: A Randomized Controlled TrialYoram Yovell, Gali Bar, Moti Mashiah, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Emotion (Washington, D.C.)|April 20, 2011
Measuring children's regulation of emotion-expressive behaviorYair Bar-Haim, Gali Bar-Av, Avi Sadeh
Biological Psychiatry|January 21, 2004
High-dose glycine added to olanzapine and risperidone for the treatment of schizophreniaUriel Heresco-Levy, Marina Ermilov, Pesah Lichtenberg, et al.
The Israel Journal of Psychiatry and Related Sciences|September 2, 2005
Characteristics of schizophrenia residents and staff rejection in community mental health hostelsEynat Levy, Gaby Shefler, Uri Loewenthal, et al.
The International Journal of Neuropsychopharmacology|December 1, 2007
Reduced prepulse inhibition is associated with increased hypnotizabilityPesach Lichtenberg, Ehud Even-Or, Gali Bar, et al.
Schizophrenia Research|February 6, 2007
High glycine levels are associated with prepulse inhibition deficits in chronic schizophrenia patientsUriel Heresco-Levy, Gali Bar, Raz Levin, et al.
Biological Psychiatry|September 15, 2004
Placebo-controlled trial of lamotrigine added to conventional and atypical antipsychotics in schizophreniaIlana Kremer, Agnes Vass, Ielena Gorelik, et al.
The Israel Medical Association Journal : IMAJ|May 1, 2017
Deliberate Self-Harm in Older Adults: A General Hospital Emergency Department SurveyIrina Briskman, Assaf Shelef, Uri Berger, et al.
Biological Psychiatry|March 23, 2005
D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophreniaUriel Heresco-Levy, Daniel C Javitt, Richard Ebstein, et al.
The American Journal of Psychiatry|December 20, 2015
Ultra-Low-Dose Buprenorphine as a Time-Limited Treatment for Severe Suicidal Ideation: A Randomized Controlled TrialYoram Yovell, Gali Bar, Moti Mashiah, et al.
Pageof 1